Drug
D1284 | serotonin
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| MITOCHONDRIA TRANSPORT | 29nM | 2h | rat | Hippocampal Neurons | time-lapse imaging experiments | increase | 215 | |
| Pictogram | Signal | Statements | Precautionary Statement Codes |
|---|---|---|---|
  |
Danger |
Aggregated GHS information provided by 193 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral] H361 (99.48%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity] Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. |
P201, P202, P264, P270, P281, P301+P310, P308+P313, P321, P330, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) |
| 1094000-36-8 | 14C-5-hydroxy tryptamine creatinine disulfate | 1H-Indol-5-ol, 3-(2-aminoethyl)- |
| 1H-Indol-5-ol,3-(2-aminoethyl)- | 2-imino-1-methylimidazolidin-4-one | 3-(.beta.-Aminoethyl)-5-hydroxyindole |
| 3-(2-Amino-ethyl)-1H-indol-5-ol | 3-(2-Aminoethyl)-1H-indol-5-o | 3-(2-Aminoethyl)-1H-indol-5-ol |
| 3-(2-Aminoethyl)-1H-indol-5-ol # | 3-(2-Aminoethyl)indol-5-ol | 3-(2-aminoethyl)-1H-indol-5-ol |
| 3-(b-Aminoethyl)-5-hydroxyindole | 3-(beta-Aminoethyl)-5-hydroxyindole | 333DO1RDJY |
| 5-22-12-00016 (Beilstein Handbook Reference) | 5-HT | 5-HYDROXYTRYPTAMINE |
| 5-Hta | 5-Hydroxy-3-(.beta.-aminoethyl)indole | 5-Hydroxy-3-(b-aminoethyl)indole |
| 5-Hydroxy-3-(beta-aminoethyl)indole | 5-Hydroxyltryptamine | 5-Hydroxytriptamine |
| 5-Hydroxytryptamine, free base | 5-hydroxy tryptamine creatinine disulfate | 5-hydroxy-tryptamine |
| 5-hydroxyl tryptamine | 5-hydroxytryptamin | 50-67-9 |
| 6996AB | 6F7FD5B4-A558-45F0-A20A-2D068A3EFE6A | AKOS001484724 |
| ALBB-006183 | API0006544 | AX8011985 |
| Antemoqua | Antemovis | BCBcMAP01_000198 |
| BDBM10755 | BPBio1_000377 | BPBio1_001079 |
| BRN 0143524 | BSPBio_000341 | BSPBio_001112 |
| Bio1_000450 | Bio1_000939 | Bio1_001428 |
| Bio2_000396 | Bio2_000876 | Biomol-NT_000083 |
| C-06146 | C00780 | CAS-153-98-0 |
| CC-21879 | CCG-204696 | CHEBI:28790 |
| CHEMBL39 | CTK4J2994 | DB-051820 |
| DB08839 | DTXSID8075330 | Ds substance |
| EINECS 200-058-9 | Enteramin | Enteramine |
| FCH832159 | FT-0631212 | GTPL5 |
| H-8000 | HMS1362H13 | HMS1792H13 |
| HMS1990H13 | HMS3403H13 | Hippophain |
| Hippophaine | IDI1_002151 | Indol-5-ol, 3-(2-aminoethyl)- |
| K-9367 | KBio2_000452 | KBio2_002472 |
| KBio2_003020 | KBio2_005040 | KBio2_005588 |
| KBio2_007608 | KBio3_000843 | KBio3_000844 |
| KBio3_002950 | KBioGR_000452 | KBioGR_002472 |
| KBioSS_000452 | KBioSS_002479 | L000078 |
| LS-83647 | Lopac-H-9523 | Lopac0_000607 |
| MCULE-8788459983 | NCGC00015525-01 | NCGC00015525-02 |
| NCGC00015525-03 | NCGC00015525-04 | NCGC00015525-05 |
| NCGC00015525-06 | NCGC00015525-07 | NCGC00015525-08 |
| NCGC00015525-09 | NCGC00142449-01 | NCGC00142449-02 |
| NCGC00142449-03 | NCGC00142449-04 | NCGC00142449-05 |
| NS00007188 | Oprea1_712368 | PDSP1_001512 |
| PDSP2_001496 | Prestwick0_000481 | Prestwick1_000481 |
| Prestwick2_000481 | Prestwick3_000481 | Q167934 |
| SCHEMBL1495 | SDCCGSBI-0050589.P002 | SMP1_000272 |
| SPBio_002262 | STK503758 | Serotonin, analytical standard |
| Serotonin;3-(2-aminoethyl)indol-5-ol;3-(2-aminoethyl)indol-5-ol--2-imino-1-methylimidazolidin-4-one sulphate (1:1) | Serotonine | Substance DS |
| Substanz DS | Thrombocytin | Thrombotonin |
| Tryptamine, 5-hydroxy- | UNII-333DO1RDJY | ZINC57058 |
| [3H]-5-HT | bis(sulfuric acid) | bmse000757 |
| cMAP_000059 | erotonin | serotonin |